☰

Finith E. Jernigan, Ph.D. - Publications

Affiliations: 
2013 Chemistry University of North Carolina, Chapel Hill, Chapel Hill, NC 
 2013-2016 Harvard Medical School, Boston, MA, United States 
 2016-2018 Silicon Therapeutics  
 2019-2020 PTC Therapeutics, Inc. 
 2020- Roivant Sciences 
Area:
Chemical Biology, Computational Drug Discovery
Tree Info Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Ghalali A, Rice JM, Kusztos A, Jernigan FE, Zetter BR, Rogers MS. Developing a novel FRET assay, targeting the binding between Antizyme-AZIN. Scientific Reports. 9: 4632. PMID 30874587 DOI: 10.1038/s41598-019-40929-4  0.406
2015 Priestman MA, Wang Q, Jernigan FE, Chowdhury R, Schmidt M, Lawrence DS. Multicolor monitoring of the proteasome's catalytic signature. Acs Chemical Biology. 10: 433-40. PMID 25347733 DOI: 10.1021/Cb5007322  0.567
2014 Oien NP, Nguyen LT, Jernigan FE, Priestman MA, Lawrence DS. Long-wavelength fluorescent reporters for monitoring protein kinase activity. Angewandte Chemie (International Ed. in English). 53: 3975-8. PMID 24604833 DOI: 10.1002/Anie.201309691  0.542
2013 Jernigan FE, Lawrence DS. A broad spectrum dark quencher: construction of multiple colour protease and photolytic sensors. Chemical Communications (Cambridge, England). 49: 6728-30. PMID 23778327 DOI: 10.1039/C3Cc42628A  0.552
2010 Agnes RS, Jernigan F, Shell JR, Sharma V, Lawrence DS. Suborganelle sensing of mitochondrial cAMP-dependent protein kinase activity. Journal of the American Chemical Society. 132: 6075-80. PMID 20380406 DOI: 10.1021/Ja909652Q  0.374
Show low-probability matches.